Selection of neoadjuvant treatment based on oncotype score in luminal breast cancer

被引:0
|
作者
Gasol Cudos, A. [1 ]
Morales Murillo, S. [1 ]
Veas Rodriguez, J. [1 ]
Canosa Morales, C. [1 ]
Mele Olive, J. [1 ]
Vilardell Villellas, F. [1 ]
Sanchez Guzman, D. R. [1 ]
Iglesias Martinez, E. [1 ]
Salud Salvia, A. [1 ]
机构
[1] Hosp Univ Arnau Vilanova Lleida, Breast Canc Unit, Lleida, Spain
来源
BREAST | 2019年 / 44卷
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
P166
引用
收藏
页码:S72 / S72
页数:1
相关论文
共 50 条
  • [41] Neoadjuvant treatment with taxanes in breast cancer
    von Minckwitz, Gunter
    BREAST CARE, 2006, 1 (03) : 176 - 184
  • [42] Neoadjuvant chemotherapy in the treatment of breast cancer
    Brain, EGC
    ANNALES DE MEDECINE INTERNE, 2000, 151 (03): : 215 - 219
  • [43] Neoadjuvant Systemic Treatment of Breast Cancer
    Makhoul, Issam
    Kiwan, Elias
    JOURNAL OF SURGICAL ONCOLOGY, 2011, 103 (04) : 348 - 357
  • [44] Neoadjuvant treatment for male breast cancer
    Fentiman, Ian Stuart
    TRANSLATIONAL CANCER RESEARCH, 2023, 12 (07) : 1669 - 1671
  • [45] Bevacizumab in Neoadjuvant Treatment for Breast Cancer
    Somlo, George
    NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (17): : 1637 - 1638
  • [46] Neoadjuvant Chemotherapy in the Treatment of Breast Cancer
    Redden, Meredith H.
    Fuhrman, George M.
    SURGICAL CLINICS OF NORTH AMERICA, 2013, 93 (02) : 493 - +
  • [47] Neoadjuvant Therapy in the Treatment of Breast Cancer
    Teshome, Mediget
    Hunt, Kelly K.
    SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA, 2014, 23 (03) : 505 - +
  • [48] ASO Visual Abstract: Discordance in Oncotype DX Breast Recurrence Score® Results for Bilateral Breast Cancer
    Joshua A. Bloom
    Yurie Sekigami
    Rebekah Young
    Lisa Macera
    Christy A. Russell
    Yu Cao
    Rachel J. Buchsbaum
    Stephen P. Naber
    Abhishek Chatterjee
    Annals of Surgical Oncology, 2021, 28 : 515 - 516
  • [49] Use of Oncotype DX Recurrence Score® (RS) reduces chemotherapy (CT) beyond treatment decisions using Ki67-based determinations of luminal A and B breast cancer subtypes: a retrospective study in the Spanish population
    Garcia-Estevez, L.
    Hernandez, E.
    Acosta, D.
    Lopez-Rios, F.
    Prieto Pozuelo, M.
    Calvo, I.
    ANNALS OF ONCOLOGY, 2016, 27
  • [50] Using Oncotype DX breast recurrence score® assay to define the role of neoadjuvant endocrine therapy in early-stage hormone receptor-positive breast cancer
    Caitlin Taylor
    Jane Meisel
    Aimee J. Foreman
    Christy Russell
    Dipankar Bandyopadhyay
    Xiaoyan Deng
    Lisa Floyd
    Amelia Zelnak
    Harry Bear
    Ruth O’Regan
    Breast Cancer Research and Treatment, 2023, 199 : 91 - 98